Of all the healthcare policies the government blasted out over the summer, one should have stood out for pharma.
The NHS is edging towards one of the most radical reforms in its history: the creation of a single national formulary (SNF).
Ministers pitch it as the end of the ‘postcode lottery’ and a bold leap towards equity, efficiency and speed of access. For pharma, however, the SNF is shaping up as both an existential challenge and a potential opportunity. The industry’s response will be critical: lean in; shape the rules and gain from standardisation – or resist and risk being shut out of the room.
Check out the rest of the article here
